Curcumin is a potent inhibitor of lymphoblasts’ proliferation in CTCL cell lines through modulation of the JAK/STAT and NF-κB signaling and induction of oxidative stress [55,56]. Here, NFKB1 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.